Influence of Obesity on Short-Term Surgical Outcomes in HFrEF Patients Undergoing CABG: A Retrospective Multicenter

Christian Jörg Rustenbach1, Stefan Reichert1, Christoph Salewski1

  • 1Department of Thoracic and Cardiovascular Surgery, German Cardiac Competence Center, Eberhard-Karls-University, 72076 Tuebingen, Germany.

Biomedicines
|February 24, 2024
PubMed

Insights

Obesity significantly increases mortality, acute kidney injury, and delirium in heart failure patients undergoing coronary artery bypass grafting (CABG). Personalized care strategies are crucial for improving outcomes in this high-risk obese population.

Area of Science:

  • Cardiology
  • Surgical Outcomes
  • Obesity Research

Background:

  • Rising global obesity rates necessitate understanding its impact on cardiovascular health.
  • Heart failure with reduced ejection fraction (HFrEF) patients undergoing coronary artery bypass grafting (CABG) represent a high-risk surgical group.
  • Obesity's specific effects on short-term surgical outcomes in HFrEF patients require investigation.

Purpose of the Study:

  • To investigate the impact of obesity on short-term surgical outcomes in patients with HFrEF undergoing CABG.
  • To compare outcomes between normal weight and obese HFrEF patients undergoing CABG.
  • To identify specific risks associated with obesity in this patient population.

Main Methods:

  • Retrospective multicenter study of 574 patients undergoing CABG (2017-2023).
  • Patients stratified into normal weight (BMI < 25 kg/m²) and obese (BMI ≥ 30 kg/m²) groups.
  • Analysis included demographics, clinical data, intraoperative management, postoperative outcomes, and laboratory results using statistical tests including binary logistic regression.

Main Results:

  • Obese patients had higher mortality (6.96% vs. 3.68%, p=0.049) and younger age (65.84 vs. 69.15 years, p=0.003).
  • Obese group showed increased need for blood transfusion, longer hospital stays (14 vs. 13 days, p=0.041), and higher ventilation times (16 vs. 13 h, p=0.049).
  • Significantly higher incidence of acute kidney injury (AKI) (17.72% vs. 9.20%, p=0.048) and delirium (p=0.016) observed in obese patients.

Conclusions:

  • Obesity is associated with significantly worse short-term surgical outcomes in HFrEF patients undergoing CABG.
  • Increased risks include mortality, acute kidney injury, and postoperative delirium.
  • Personalized perioperative care and further tailored research are essential for this high-risk obese population.

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
368
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
324
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
460